216 related articles for article (PubMed ID: 8896449)
1. The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.
Aso T; Haque D; Barstead RJ; Conaway RC; Conaway JW
EMBO J; 1996 Oct; 15(20):5557-66. PubMed ID: 8896449
[TBL] [Abstract][Full Text] [Related]
2. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein.
Takagi Y; Pause A; Conaway RC; Conaway JW
J Biol Chem; 1997 Oct; 272(43):27444-9. PubMed ID: 9341197
[TBL] [Abstract][Full Text] [Related]
3. Characterization of elongin C functional domains required for interaction with elongin B and activation of elongin A.
Takagi Y; Conaway RC; Conaway JW
J Biol Chem; 1996 Oct; 271(41):25562-8. PubMed ID: 8810329
[TBL] [Abstract][Full Text] [Related]
4. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II.
Aso T; Lane WS; Conaway JW; Conaway RC
Science; 1995 Sep; 269(5229):1439-43. PubMed ID: 7660129
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transcription elongation by the VHL tumor suppressor protein.
Duan DR; Pause A; Burgess WH; Aso T; Chen DY; Garrett KP; Conaway RC; Conaway JW; Linehan WM; Klausner RD
Science; 1995 Sep; 269(5229):1402-6. PubMed ID: 7660122
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of DNAs encoding the regulatory subunits of elongin from Saccharomyces cerevisiae and Drosophila melanogaster.
Aso T; Conrad MN
Biochem Biophys Res Commun; 1997 Dec; 241(2):334-40. PubMed ID: 9425272
[TBL] [Abstract][Full Text] [Related]
7. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide.
Botuyan MV; Mer G; Yi GS; Koth CM; Case DA; Edwards AM; Chazin WJ; Arrowsmith CH
J Mol Biol; 2001 Sep; 312(1):177-86. PubMed ID: 11545595
[TBL] [Abstract][Full Text] [Related]
8. Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.
Kamura T; Burian D; Yan Q; Schmidt SL; Lane WS; Querido E; Branton PE; Shilatifard A; Conaway RC; Conaway JW
J Biol Chem; 2001 Aug; 276(32):29748-53. PubMed ID: 11384984
[TBL] [Abstract][Full Text] [Related]
9. Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase.
Brower CS; Sato S; Tomomori-Sato C; Kamura T; Pause A; Stearman R; Klausner RD; Malik S; Lane WS; Sorokina I; Roeder RG; Conaway JW; Conaway RC
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10353-8. PubMed ID: 12149480
[TBL] [Abstract][Full Text] [Related]
10. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C.
Botuyan MV; Koth CM; Mer G; Chakrabartty A; Conaway JW; Conaway RC; Edwards AM; Arrowsmith CH; Chazin WJ
Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9033-8. PubMed ID: 10430890
[TBL] [Abstract][Full Text] [Related]
11. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC.
Feldman DE; Thulasiraman V; Ferreyra RG; Frydman J
Mol Cell; 1999 Dec; 4(6):1051-61. PubMed ID: 10635329
[TBL] [Abstract][Full Text] [Related]
12. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
Schoenfeld AR; Davidowitz EJ; Burk RD
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011
[TBL] [Abstract][Full Text] [Related]
13. The elongin B ubiquitin homology domain. Identification of Elongin B sequences important for interaction with Elongin C.
Brower CS; Shilatifard A; Mather T; Kamura T; Takagi Y; Haque D; Treharne A; Foundling SI; Conaway JW; Conaway RC
J Biol Chem; 1999 May; 274(19):13629-36. PubMed ID: 10224134
[TBL] [Abstract][Full Text] [Related]
14. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.
Pause A; Lee S; Worrell RA; Chen DY; Burgess WH; Linehan WM; Klausner RD
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2156-61. PubMed ID: 9122164
[TBL] [Abstract][Full Text] [Related]
15. Comparative sequence analysis of the VHL tumor suppressor gene.
Woodward ER; Buchberger A; Clifford SC; Hurst LD; Affara NA; Maher ER
Genomics; 2000 May; 65(3):253-65. PubMed ID: 10857749
[TBL] [Abstract][Full Text] [Related]
16. Identification and biochemical characterization of a novel transcription elongation factor, Elongin A3.
Yamazaki K; Guo L; Sugahara K; Zhang C; Enzan H; Nakabeppu Y; Kitajima S; Aso T
J Biol Chem; 2002 Jul; 277(29):26444-51. PubMed ID: 11994304
[TBL] [Abstract][Full Text] [Related]
17. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families.
Kamura T; Sato S; Haque D; Liu L; Kaelin WG; Conaway RC; Conaway JW
Genes Dev; 1998 Dec; 12(24):3872-81. PubMed ID: 9869640
[TBL] [Abstract][Full Text] [Related]
18. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.
Kibel A; Iliopoulos O; DeCaprio JA; Kaelin WG
Science; 1995 Sep; 269(5229):1444-6. PubMed ID: 7660130
[TBL] [Abstract][Full Text] [Related]
19. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.
Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER
Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel protein (VBP-1) binding to the von Hippel-Lindau (VHL) tumor suppressor gene product.
Tsuchiya H; Iseda T; Hino O
Cancer Res; 1996 Jul; 56(13):2881-5. PubMed ID: 8674032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
